Search Results - "Borison, Richard L"

Refine Results
  1. 1
  2. 2

    Changing antipsychotic medication: guidelines on the transition to treatment with Risperidone by Borison, Richard L

    Published in Clinical therapeutics (01-07-1996)
    “…When treating patients with psychoses, clinicians must often consider changing their treatment from one antipsychotic agent to another. The transition may be…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Phenomenology and neurobiology of cocaine withdrawal: Are they related? by Pathiraja, Ananda, Marazziti, Donatella, Cassano, Giovanni B., Diamond, Bruce I., Borison, Richard L

    “…1. 1. The presence of mood disturbances and platelet 3H-imipramine binding, a putative peripheral serotonergic marker, were evaluted in a group of 27 cocaine…”
    Get full text
    Journal Article
  5. 5

    A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease by Knapp, Margaret J, Knopman, David S, Solomon, Paul R, Pendlebury, William W, Davis, Charles S, Gracon, Stephen I, Apter, Jeffrey T, Lazarus, Clifford N, Baker, Karen E, Barnett, Michael, Baumel, Barry, Eisner, Larry S, Bennett, David, Forchetti, Concetta, Levin, Amy, Blass, John P, Nolan, Karen A, Gaines, Eleonore R, Relkin, Norman, Borison, Richard L, Diamond, Bruce, Celesia, Gastone G, Ross, Amy Perrin, Dexter, James, Doody, Rachelle, Lipscomb, Lisa, Kreiter, Kurt, DuBoff, Eugene A, Block, Paul, Marshall, Deborah, Westergaard, Nancy, Earl, Nancy L, Vann Wyne, Sarah, Hinman-Smith, Elisabeth, Farlow, Martin, Hendrie, Hugh C, Caress, Judith A, Farmer, Mildred, Harper, Jane E, Ferguson, James, Foster, Norman L, Barbas, Nancy R, Bluemlein, Laurie A, Gelb, Douglas J, Berent, Stanley, Giordani, Bruno, Greenwald, Maria, Bergman, Scott, Roger, Linda F, Groenendyk, Adrian, Wood, Myrna, Jurkowski, Claire, Katz, Ira, Doyle, Suzanne, Smith, Buster D, Kellner, Charles, Bernstein, Hilary J, Bachman, David L, Deinard, Susan, Langley, Linda, Bridges, Sarah, Margolin, Richard A, Burger, Mary Candice, Wiser, Susan Longwith, Crenshaw, Caryn, Morris, John C, Rubin, Eugene H, Coats, Mary A, Reyes, Patricio F, Bentz, Catherine, Doyle, Lara L, Rymer, Marilyn M, Bettinger, Irene E, Laubinger, M. Pat, Sadowsky, Carl H, Martinez, Walter, Zuniga, José, Stone, Reed, Winner, Paul, Maté, Lazlo, Lessard, Carla, Schneider, Lon, Pawluczyk, Sonia, Smith, Ward T, Losk, Scott N, Marambe, Linda, Groccia-Ellison, Mary Ellen, Edwards, Keith R, Taylor, John, Calabrese, Vincent P, Harkins, Stephen W, Thein, Stephen G, Dewar, Judith A, Williams, Geri, Drennan, Carol, Tuttle, Paul, Principi, Nancy, Ford, Elaine M, Tyndall, Robert J, Kelley, Connie K

    “…Objective.—To evaluate the efficacy and safety of high-dose tacrine hydrochloride over 30 weeks in patients with probable Alzheimer's disease.Design.—A 30-week…”
    Get full text
    Journal Article
  6. 6

    Lithium and Lupuslike Syndrome by Shukla, Vikram R, Borison, Richard L

    “…To the Editor.—A common side effect associated with lithium carbonate administration is a rash, possibly related to lithium's action on immunologic function.1…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics by Borison, R L

    Published in Journal of clinical psychopharmacology (01-02-1995)
    “…Serotonin-dopamine antagonists (SDAs) offer the possibility of improved treatment of schizophrenia compared with conventional neuroleptics and have superior…”
    Get full text
    Journal Article
  10. 10

    A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study by Möller, H J, Müller, H, Borison, R L, Schooler, N R, Chouinard, G

    “…The hypothesis that differences in drug effects of risperidone and haloperidol on negative symptoms in schizophrenia are secondary to effects on positive,…”
    Get full text
    Journal Article
  11. 11

    Recent advances in the pharmacotherapy of schizophrenia by Borison, R L

    Published in Harvard review of psychiatry (01-01-1997)
    “…The limitations of standard antipsychotics have spurred a search for novel agents that are effective against both positive and negative symptoms of…”
    Get more information
    Journal Article
  12. 12

    A comparison of venlafaxine, trazodone, and placebo in major depression by Cunningham, L A, Borison, R L, Carman, J S, Chouinard, G, Crowder, J E, Diamond, B I, Fischer, D E, Hearst, E

    Published in Journal of clinical psychopharmacology (01-04-1994)
    “…A double-blind, placebo-controlled trial was undertaken to compare the safety and efficacy of venlafaxine and trazodone in patients with major depression. Two…”
    Get more information
    Journal Article
  13. 13

    The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients by Walczak, D D, Apter, J T, Halikas, J A, Borison, R L, Carman, J S, Post, G L, Patrick, R, Cohn, J B, Cunningham, L A, Rittberg, B, Preskorn, S H, Kang, J S, Wilcox, C S

    Published in Annals of clinical psychiatry (01-09-1996)
    “…This 7- to 8-week, multicenter, randomized, double-blind, placebo-controlled study was performed to determine the dose-effect relationship and minimum…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Enkephalins and nigrostriatal function by Diamond, B I, Borison, R L

    Published in Neurology (01-11-1978)
    “…Unilateral lesions of the substantia nigra were made with 6-hydroxydopamine in rats. In this model, drugs such as naloxone, which block endogenous enkephalin…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Regional selectivity of neuroleptic drugs: an argument for site specificity by Borison, R L, Diamond, B I

    Published in Brain research bulletin (01-01-1983)
    “…Differences among neuroleptic drugs in their abilities to produce extrapyramidal side-effects have alternatively been ascribed to their inherent…”
    Get more information
    Journal Article
  19. 19

    Treatment approaches in Gilles de la Tourette syndrome by Borison, R L, Ang, L, Hamilton, W J, Diamond, B I, Davis, J M

    Published in Brain research bulletin (01-08-1983)
    “…The neurological disorder Gilles de la Tourette syndrome is most often treated with the receptor blocker haloperidol, which also produces multiple…”
    Get more information
    Journal Article
  20. 20